Biotechnology · Healthcare
Board Member, Chairman
2025-11-06–present
Board Member
Acumen Pharmaceuticals, Inc. (ABOS)Chairman
Acumen Pharmaceuticals, Inc. (ABOS)Equibles does not estimate personal net worth.
Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ABOS alertsDr. George Golumbeski is recorded as Board Member and Chairman at Acumen Pharmaceuticals, Inc. (ABOS) since November 6, 2025. Acumen Pharmaceuticals, Inc. reported in an 8-K filed November 10, 2025 that Dr. George Golumbeski was appointed Chairman of the Board, effective November 6, 2025. Acumen Pharmaceuticals, Inc. reported in an 8-K filed November 10, 2025 that Dr. George Golumbeski was appointed director, effective November 6, 2025. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Matthew Zuga (CFO), Russell Barton (COO) and 1 other.
“Dr. Golumbeski has also been appointed to replace Dr. Sean Stalfort as Chairman of the Board.”
“On November 6, 2025, the Board of Directors (the "Board") of Acumen Pharmaceuticals, Inc. (the "Company") approved the appointment of Dr. George Golumbeski to serve as a director of the Board, effective November 6, 2025 (the "Effective Date").”
2025-11-06–present
2025-11-06–present
Biotechnology · Healthcare
Board Member, Chairman
2025-11-06–present